BRIGHT MINDS BIOSCIENCES INC. - COMMON STOCK, WITHOUT PAR VALUE (DRUG)

CUSIP: 10919W405

Q2 2025 13F Holders as of 30 Jun 2025

Holder snapshot 6 signals
Share change
+17,931
SEC-reported price per share
$26.11
Number of holders
46
Value change
-$2,453,899
Number of buys
28
Number of sells
17
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
10,194,635

Security key

10919W405

Report period

Q2 2025

Institutions

46

Top holders

10

Ownership snapshot

Top reported holders of DRUG - BRIGHT MINDS BIOSCIENCES INC. - COMMON STOCK, WITHOUT PAR VALUE (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Ian McDonald
Disclosed value leader
Ian McDonald
Comparable rows
15/15
Latest evidence
31 Mar 2025
13D/G 13F Lead comparable stake: 14% 13D/G row: Ian McDonald Showing 1-6 of 15 holder rows.

Quick read

Ian McDonald leads the comparable SEC ownership view at 14%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Ian McDonald's linked filing trail.
Comparable ownership Top 5
Ian McDonald 14%
Point72 Asset Management, L.P. 3%
RA CAPITAL MANAGEMENT, L.P. 2.9%
Janus Henderson Group Ltd. 11%
Cormorant Asset Management, LP 10%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Ian McDonald
13D/G
14%
$85,992,664
1,396,665 shares
$0 04 Nov 2024
Point72 Asset Management, L.P.
13F 13D/G
Company
3%
from 13D/G
$4,870,171
135,020 shares
31 Mar 2025
RA CAPITAL MANAGEMENT, L.P.
13F 13D/G
Company
2.9%
from 13D/G
$7,445,822
206,427 shares
31 Mar 2025
Janus Henderson Group Ltd.
13F
Company
13F
11%
$40,275,976
1,111,368 shares
31 Mar 2025
Cormorant Asset Management, LP
13F
Company
13F
10%
$38,210,069
1,059,331 shares
31 Mar 2025
Sio Capital Management, LLC
13F
Company
13F
5%
$18,307,761
507,562 shares
31 Mar 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
46
Shares
5,234,387
Rows available
46
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
34
Q2 2025 holders
46
Holder diff
12
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 value Q2 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .